SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001640455-20-000042
Filing Date
2020-04-29
Accepted
2020-04-29 16:36:25
Documents
5
Period of Report
2020-04-28
Effectiveness Date
2020-04-29

Document Format Files

Seq Description Document Type Size
1 DEF 14A jnce04292020def14a.htm DEF 14A 510756
2 jnceproxycard001.jpg GRAPHIC 148942
3 jnceproxycard002.jpg GRAPHIC 118952
4 jouncelogo.jpg GRAPHIC 66963
5 rmsignature.jpg GRAPHIC 2641
  Complete submission text file 0001640455-20-000042.txt   976932
Mailing Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139
Business Address 780 MEMORIAL DRIVE CAMBRIDGE MA 02139 857-259-3840
Jounce Therapeutics, Inc. (Filer) CIK: 0001640455 (see all company filings)

IRS No.: 454870634 | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-37998 | Film No.: 20830913
SIC: 2836 Biological Products, (No Diagnostic Substances)